Systemic Lupus Erythematosus (SLE) is a multifaceted autoimmune disease that can affect multiple organ systems, with joint involvement being one of its most prevalent manifestations. In many ...

International Journal of Clinical Rheumatology Managing CNS Involvement in Systemic Lupus Erythematosus Matteo Piga; Alessandro Mathieu Disclosures Int J Clin Rheumatol. 2011;6 (5):547-567. 0 ...

The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus (SLE) with extrarenal involvement. The FDA’s ...

The study cohort comprised 41,095 patients with SLE, including 19,631 who received THA and 21,464 who received TKA. Overall, 30-day readmission rates were 6.1% for THA and 4.8% for TKA.

ADI-001 was granted Fast Track Designation by the FDA for the treatment of relapsed/refractory class III or class IV lupus nephritis (LN), and SLE with extrarenal involvement.

IL-2 stands for interleukin-2 – a molecule that plays an integral role in the immune system. Defective IL-2 production contributes to the unbalanced immune system in SLE. Rash, lower complement 3 (C3) ...

The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus (SLE) with extrarenal involvement. The FDA’s ...